DANNY MCCLURE: Open Payments
NPI 1073855409 · TAMUNING, GU. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$78,555 in 109 payments from 4 companies in 2025. Trend: 2023 $81,149 · 2024 $83,595 · 2025 $78,555
Speaker / faculty: $31,774Honoraria: $30,925Consulting: $7,400Travel & lodging: $6,382Food & beverage: $2,075
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 54 | $35,647 |
| Alkermes, Inc. | 21 | $17,784 |
| Neurocrine BioSciences, Inc. | 22 | $17,339 |
| Otsuka America Pharmaceutical, Inc. | 12 | $7,786 |
Products named: Auvelity, LYBALVI, INGREZZA, REXULTI.
Industry payments across GU — which companies pay providers there.
